ABOUT DR. LUCY OSEI ABABIO

Dr. Lucy Osei Ababio is a Senior Medical Officer at the Navrongo Health Research Centre, renowned for her exceptional contributions to Public Health through cutting-edge research and clinical trials.

Her work focuses on advancing healthcare innovations, particularly in infectious diseases, vaccine efficacy, and the management of chronic conditions such as Sickle Cell Disease.

In her role, Dr. Osei Ababio provides vital medical care to research participants, ensuring their safety and well-being throughout trials. She leads multidisciplinary research studies, designs protocols, and authors manuscripts for publication in peer-reviewed journals. Her academic rigor and dedication to sharing knowledge are evident in her mentorship of research assistants and students, as well as her community outreach efforts to educate the public on pressing health issues.

Dr. Osei Ababio has contributed significantly to several groundbreaking studies, including:

• Evaluating the efficacy, immunogenicity, and safety of COVID-19 vaccines in adults.
• Participating in a Phase 1 trial of a Lassa virus vaccine in healthy adults.
• Researching the safety, tolerability, and pharmacokinetics of anti-malarial agents in both children and adults.
• Leading malaria vaccine studies to combat one of the world’s most challenging public health threats.

A notable achievement in her career is her work on Sickle Cell Disease. Dr. Osei Ababio spearheaded an implementation study to integrate point-of-care testing (POCT) technology into primary healthcare, facilitating the diagnosis and care of over 600 newborns with Sickle Cell Disease. She also established the Sickle Cell Clinic at War Memorial Hospital, providing counseling and care to more than 180 patients, demonstrating her unwavering commitment to improving the lives of vulnerable populations.

Dr. Osei Ababio earned her medical degree from the University for Development Studies and is currently pursuing an MSc in Clinical Trials at the London School of Hygiene and Tropical Medicine, further enhancing her expertise in advancing global health research.

Her work exemplifies a synergy of clinical excellence, research innovation, and a passion for mentorship, positioning her as a pivotal figure in Public Health, Clinical Trials, Sickle Cell Disease research, and Vaccine Development.